268 related articles for article (PubMed ID: 25732009)
1. Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.
Didier A; Bons B
Expert Opin Drug Saf; 2015 May; 14(5):777-88. PubMed ID: 25732009
[TBL] [Abstract][Full Text] [Related]
2. An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents.
Eberle P; Brueck H; Gall R; Hadler M; Sieber J; Karagiannis E
Pediatr Allergy Immunol; 2014 Dec; 25(8):760-6. PubMed ID: 25378225
[TBL] [Abstract][Full Text] [Related]
3. Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.
Didier A; Wahn U; Horak F; Cox LS
Expert Rev Clin Immunol; 2014 Oct; 10(10):1309-24. PubMed ID: 25205329
[TBL] [Abstract][Full Text] [Related]
4. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
[TBL] [Abstract][Full Text] [Related]
5. Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials.
Casale TB; Cox LS; Wahn U; Golden DBK; Bons B; Didier A
J Allergy Clin Immunol Pract; 2017; 5(6):1717-1727.e1. PubMed ID: 28734858
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
[TBL] [Abstract][Full Text] [Related]
7. Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study.
Shah-Hosseini K; Krudewig EM; Hadler M; Karagiannis E; Mösges R
Adv Ther; 2017 Jun; 34(6):1382-1397. PubMed ID: 28455783
[TBL] [Abstract][Full Text] [Related]
8. Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis.
Gerstlauer M; Szepfalusi Z; Golden D; Geng B; de Blic J
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):70-80. PubMed ID: 31009701
[TBL] [Abstract][Full Text] [Related]
9. Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study.
Pfaar O; Richter HG; Klimek L; Sieber J; Hadler M; Karagiannis E
Biomed Res Int; 2015; 2015():584291. PubMed ID: 26351635
[TBL] [Abstract][Full Text] [Related]
10. Optimum treatment strategies for polyallergic patients - analysis of a large observational trial.
Shah-Hosseini K; Mioc K; Hadler M; Karagiannis E; Mösges R
Curr Med Res Opin; 2015 Dec; 31(12):2249-59. PubMed ID: 26366617
[TBL] [Abstract][Full Text] [Related]
11. Persistence of treatment with 5-grass pollen tablets in patients with allergic rhinitis: a real-life study.
Ras L; de Groot H; Stengs CH; van Weissenbruch R
Ann Allergy Asthma Immunol; 2016 Jan; 116(1):52-58.e2. PubMed ID: 26596408
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of the SQ Tree SLIT Tablet in Adults.
Birk AO; Andersen JS; Villesen HH; Steffensen MA; Calderon MA
Clin Ther; 2017 Sep; 39(9):1858-1867. PubMed ID: 28844318
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
14. SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.
Dahl R; Roberts G; de Blic J; Canonica GW; Kleine-Tebbe J; Nolte H; Lawton S; Nelson HS
Allergy Asthma Proc; 2016; 37(2):92-104. PubMed ID: 26802643
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
[TBL] [Abstract][Full Text] [Related]
16. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
17. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
Senna GE; Calderon M; Milani M
Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
[TBL] [Abstract][Full Text] [Related]
18. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
Didier A; Worm M; Horak F; Sussman G; de Beaumont O; Le Gall M; Melac M; Malling HJ
J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
[TBL] [Abstract][Full Text] [Related]
19. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
Devillier P; Wahn U; Zielen S; Heinrich J
Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
[TBL] [Abstract][Full Text] [Related]
20. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.
Maloney J; Prenner BM; Bernstein DI; Lu S; Gawchik S; Berman G; Kaur A; Li Z; Nolte H
Ann Allergy Asthma Immunol; 2016 Jan; 116(1):59-65. PubMed ID: 26553448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
